Brief: Dimerix Announces Phase 3 Study In FSGS Kidney Patients Commences
25/08/2021 02:24
Aug 25 (Reuters) - Dimerix Ltd DXB.AX :
* DIMERIX LTD - PHASE 3 STUDY IN FSGS KIDNEY PATIENTS COMMENCES
* DIMERIX - ON TRACK TO BEGIN PATIENT RECRUITMENT FOR STUDY ONCE ETHICS
APPROVAL
ACHIEVED, WITH FIRST PATIENT SCREENING EXPECTED IN Q4 2021
Source text for Eikon: ID:nASX8rLp2Q
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions